Evidence map›Paper›PMID 10540221›Full record

ArticleImmunology1999

Differential modes of regulation of interleukin-1beta expression by extracellular matrices.

J Roman, J D Ritzenthaler, R L Perez, S L Roser

Open access · greenAbstract read
In one paragraph

Article in Immunology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 25 citations in OpenAlex.

  1. International journal of molecular sciences · 2023
    Article
  2. Interleukin-1 Beta-A Friend or Foe in Malignancies?International journal of molecular sciences · 2018
    Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

J RomanPulmonary & Critical Care Division, Department of Medicine, Atlanta Veterans Affairs Medical Center, Decatur, GA 30033, USA.
J D Ritzenthaler
R L Perez
S L Roser
Emory University · US

Funding

FIBRONECTIN IN PULMONARY TUBERCULOSISR01HL051639 · NHLBI · EMORY UNIVERSITY · PI ROMAN-RODRIGUEZ, JESSE · 1993 to 1997
–
NHLBI NIH HHS HL51639Wellcome Trust
6 · The paper itself

Abstract

Extracellular matrices (ECMs) can stimulate human monocytic cells to express interleukin-1beta (IL-1beta), a proinflammatory cytokine implicated in the regulation of tissue inflammation. In this study, we explored the intracellular mechanisms responsible for ECM induction of IL-1beta using human promonocytic U937 cells transfected with the full-length human IL-1beta gene promoter connected to a reporter gene. Using this system, we demonstrated that the ECM molecules fibronectin (FN), type I collagen (Coll), fibrin (Fb) and laminin (Lm) induced transcription of the IL-1beta gene (which was associated with a modest increase in IL-1beta protein secretion) in suspended cells, when used in their soluble monomeric form. This effect was mimicked or blocked by anti-integrin monoclonal antibodies (mAbs) and was dependent on the activation of protein kinase C (PKC). Three of the ECMs tested (FN, Coll and Fb) induced the activation of mitogen-activated protein kinases (MAPKs), whereas Lm had no effect. FN, Coll and Fb (but not Lm) also induced DNA binding of the transcription factor activator protein-1 (AP-1), but not that of nuclear factor-kappaB. Co-transfection of U937 cells with a competing AP-1 oligomer blocked the IL-1beta response induced by FN, but not that induced by the other ECMs. By inhibiting AP-1 translocation, glucocorticoids also blocked the FN-induced response, but not that of the other ECMs. These studies suggest that the signalling pathways which mediate ECM induction of IL-1beta expression in human monocytic cells converge at the level of PKC activation. However, they diverge in other aspects, as demonstrated by the differential activation of MAPKs and the need for diverse transcription factors.

Indexed as

Administration, TopicalAndrostadienesAnti-Inflammatory AgentsCell LineCollagenExtracellular MatrixExtracellular Matrix ProteinsFibrinFibronectinsFluticasoneGlucocorticoidsHumansInterleukin-1LamininMacrophagesMitogen-Activated Protein KinasesAndrostadienesAnti-Inflammatory AgentsCollagenExtracellular Matrix ProteinsFibrinFibronectinsFluticasoneGlucocorticoidsInterleukin-1LamininMitogen-Activated Protein KinasesNF-kappa BTranscription Factor AP-1

Identifiers

PMID10540221
PMCPMC2326922
OpenAlexW2064928942

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.